WPRIM Management System> DCMS> Practical Oncology Journal> 2019> 33> 4

Volume: 33 Issue: 4

1. Relationship between the methylation status of CpG island in STAT1,STAT3 gene promoters in peripheral blood and prog-nosis of colorectal cancer Page:346—351
2. Clinical study of docetaxel in the treatment of metastatic breast cancer in different age groups Page:352—356
3. Advances progress of N6-methyladenine and cancer Page:357—360
4. Progress of correlation between bone marrow dose-volume parameters and acute hematologic toxicity in pelvic malignant tumor Page:361—366
5. Advanced in the relation between long-chain non-coding RNA CCAT1 and digestive system malignancies Page:367—370
6. Mechanism and recent progress of gastric cancer in immunological checkpoint inhibitors Page:371—375
7. Advances in research on treatment of aberrant crypt foci Page:376—379
8. Advance of whole brain radiotherapy irradiation of hippocampus in the treatment of small cell lung cancer Page:380—383
9. Polyphenylene-polysaccharide complex from pinus koraiensis extract induces apoptosis in human breast cancer MCF-7 cells Page:289—293
10. Effect of CaMKIIγ RNA interference on the expression of NFATc1,TRAP and c-Src genes in osteoclast differentiation Page:294—299
11. Effect of miRNA-409-3p expression on proliferation of cervical cancer cells and chemotherapy sensitivity of cisplatin Page:300—304
12. Mechanism study of sanguinarine inhibiting tumor growth of ovarian cancer by apoptosis induction Page:305—309
13. A study on the mechanism of mi-362 targeting six1 inhibiting proliferation and migration of cervical cancer cells Page:310—316
14. Expression and mechanism of TMEM45A in renal clear cell carcinoma Page:317—322
15. Expression and significance of FBXW10 and cyclin E in renal clear cell carcinoma Page:323—327
16. Expression of CSN6 gene in hepatocellular carcinoma tissues and its clinical significance Page:328—333
17. Expression of MAGEA4 and EB1 proteins in lung cancer tissues and their correlation with clinicopathological features and prognosis Page:334—339
18. Growth differentiation factor 15 plays a role in predicting and monitoring the cardiotoxicity of epirubicin/cyclophosphamide-docetaxel-trastuzumab in the treatment of patients with HER-2 positive breast cancer Page:340—345

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.